AL Amyloidosis and Anti-CD38-Daratunumab
Clinical trial NCT06571864 · COMPLETED
Trial details
- NCT number
- NCT06571864
- Sponsor
- University of Turin, Italy
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-02
- Primary completion
- 2024-01-02
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.